Tracheotomy With and Without Dual Antiplatelet Therapy — PDT and (D)APT  

Tracheostomy Hemorrhage Clinical Trial

Official title: Evaluation of the Safety of Percutaneous Tracheotomies in Intensive Care Patients With and Without Antiplatelet Therapy and Comparison of Two Tracheotomy Techniques

Status Recruiting

Clinical Trial Summary

Platelet-inhibiting drugs are often used after vascular interventions. Patients who require such therapies are often critically ill, are treated in intensive care units and often require long-term ventilation. For long-term ventilation a tracheotomy is necessary, which is usually performed as a percutaneous dilatative tracheotomy (PDT). As part of this intervention, there is (theoretically) an increased risk of bleeding/an increased rate of complications in patients with a antiplatelet therapy. In addition, there are various techniques for performing a PDT.

The current study aims to investigate the frequency of bleeding/complications taking into account the technique used in PDT.

Clinical Trial Description

n/a

Related Conditions & MeSH terms

• Hemorrhage
• Tracheostomy Hemorrhage

• NCT number: NCT05058469
• Study type: Observational
• Source: Asklepios Neurological Clinic Bad Salzhausen
• Contact: Dirk Bandorski, MD
• Phone: +496043804212
• Email: d.bandorski@asklepios.com
• Status: Recruiting
• Start date: October 1, 2022
• Completion date: December 2024